Venrock puts together a $350 million fund
By Brandon Glenn Jumping on the venture capital industry’s less-is-more bandwagon, Venrock put together a $350 million fund, down more than 40 percent from its last funding pool. Unlike in years past,...
View ArticleCancer: RefleXion Medical raises $11.6M to ‘make radiotherapy personal’
California-based medtech group RefleXion Medical touted an $11.6 million Series A fundraising round, hoping to use the new funds to expand research & development efforts for its guided radiation...
View ArticleDOD hands out $99.6 million in contracts to Hologic, GE, PositiveID | Medtech...
Hologic, GE, PositiveID land near $100M in Defense contracts April 7, 2014 by Arezu Sarvestani The U.S. Dept. of Defense handed out $99.6 million in contracts to a trio of device makers, providing for...
View ArticlePowerVision raises $30M for FluidVision implantable lens
Ophthalmic devices maker PowerVision finally put a ribbon on its $30 million Series D funding round, planning on using the funds to advance clinical trials in support of regulatory approvals in Europe...
View ArticlePowerVision gains $30 million in funding round | Medtech funding for the week...
PowerVision raises $30M for FluidVision implantable lens June 16, 2014 by Arezu Sarvestani Ophthalmic devices maker PowerVision finally put a ribbon on its $30 million Series D funding round, planning...
View ArticleSpirox lands $19m Series B round
Spirox said this week that it nailed down an $18.5 million Series B round to back development and commercialization of its device to treat patients with nasal obstructions. Venrock and Aisling Capital...
View ArticleMedtech investment in MN falls back to earth | Medtech funding for the week...
Medtech investment in Minnesota falls back to earth April 17, 2015 by Scott Wooldridge After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical...
View ArticleVenrock raises $400m for third healthcare fund
Venrock has raised $400 million for its Venrock Healthcare Capital Partners III cross-over biotech fund, according to an SEC filing posted this week. The total funds raised include a commitment from...
View Article
More Pages to Explore .....